Between 2000 and 2007, mortality due to dementia more than doubled; the FDA has granted fast-track designation for an opioid antidote from Purdue Pharma, the pharmaceutical company accused of aggressively marketing OxyContin; physicians say prior authorization is interfering with continuity of care.
Mortality rates due to dementia more than doubled since 2000, jumping from 30.5 deaths per 100,000 in 2000 to 66.7 in 2017, according to a National Statistics Report from CDC. These death rates varied by age, sex, race, and geographic location, and in 2017, the majority of deaths occurred in nursing homes or other long-term care facilities. According to the report, taking into account mortality from all 4 causes of dementia would have made dementia the third-leading cause of death in the United States in 2017.
The FDA has granted fast-track designation for an experimental opioid overdose drug from Purdue Pharma, the pharmaceutical company currently under fire and facing lawsuits for allegedly aggressively and deceptively marketing OxyContin, reported CNN. According to the drug maker, their opioid antidote, nalmefene hydrochloride injection, has a longer effect than naloxone.
A report from the American Medical Association found that the use of prior authorization has greatly increased in the last 5 years, and the overwhelming majority (85%) of physicians say that the process interferes with continuity of care. The survey of 1000 physicians in December 2018 also found that nearly 7 in 10 physicians find it difficult to determine whether the prescription or medical service requires prior authorization.
CMS' 340B Repayment Proposal May Harm Vulnerable Hospitals, Reward Those With Higher Revenues
April 26th 2024The 340B hospitals not receiving an offsetting lump-sum payment from CMS following 2018-2022 cuts later ruled unlawful are disproportionately rural, publicly owned, and nonacademic, according to a new study.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More
CMS' 340B Repayment Proposal May Harm Vulnerable Hospitals, Reward Those With Higher Revenues
April 26th 2024The 340B hospitals not receiving an offsetting lump-sum payment from CMS following 2018-2022 cuts later ruled unlawful are disproportionately rural, publicly owned, and nonacademic, according to a new study.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More
2 Commerce Drive
Cranbury, NJ 08512